Position in VCYT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,356,668
-$279,214 QoQ
Shares Held
104,212
+20.7% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $69,634,221 across 18 Diagnostics & Research names. VCYT ranks #6 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
25,899 | $14,552,389 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
29,028 | $14,268,132 | |
| 3 | DHR |
Danaher Corp /De/
|
48,612 | $9,216,835 | |
| 4 | NTRA |
Natera, Inc.
|
22,942 | $4,588,170 | |
| 5 | TWST |
Twist Bioscience Corp
|
96,255 | $4,574,037 | |
| 6 | VCYT |
Veracyte, Inc.
This page
|
104,212 | $3,356,668 | |
| 7 | GRAL |
GRAIL, Inc.
|
55,423 | $2,864,260 | |
| 8 | A |
Agilent Technologies, Inc.
|
21,858 | $2,491,374 |
All Filings in VCYT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,356,668 | 104,212 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,635,882 | 86,363 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,244,699 | 94,515 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,941,458 | 108,822 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,290,230 | 110,969 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,577,939 | 90,352 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,078,135 | 90,427 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,385,953 | 110,104 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,837,667 | 308,559 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,386,882 | 159,465 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,743,360 | 212,421 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,199,448 | 243,402 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,483,635 | 290,746 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $6,685,405 | 281,728 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,737,242 | 345,617 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,959,721 | 198,981 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,196,715 | 224,763 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,539,340 | 134,450 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,974,286 | 64,032 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,885,556 | 72,175 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,412,802 | 63,494 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $761,800 | 15,566 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,461,107 | 44,971 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $560,501 | 21,641 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||